By TOAST classification, MES were found in 9 of 48 patients with high-grade atherosclerosis, 8 of 24 with cardiac embolic sources, 4 of 45 with undetermined cause, and 13 of 45 with other determined etiologies
Six mild to moderate adverse events occurred during the study, but no serious events were reported
BPC-157 appears to accelerate the formation of new microvessels by increasing VEGF expression in fibroblasts and endothelial cells, effectively fast-forwarding the vascularization phase of healing
Recent research from 2025 reveals concerning findings that should make anyone considering glutathione injections pause and reconsider
Novo Nordisk Patients Seeking Upgrade CagriSema Patients already on semaglutide (Wegovy) who need greater weight loss can potentially upgrade to CagriSema within the Novo Nordisk ecosystem once approved, leveraging the same GLP-1 component plus added amylin agonism
NAD+ and Mitochondrial Health After 40: The Cellular Energy Connection Explore NAD+ and mitochondrial health after 40, including cellular energy, focus, recovery, healthy aging, and what human clinical studies suggest today